We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » UK Lawmakers Want More Sunshine on Trial Data, Point to Tamiflu
UK Lawmakers Want More Sunshine on Trial Data, Point to Tamiflu
Doctors and researchers should have full access to clinical trial data on products licensed in the UK to ensure that the cost-benefits, as well as safety and efficacy, are considered in prescribing and coverage decisions, lawmakers say.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor